Prescription drug · NDA
Neurontin (Gabapentin) NDC 58151-290
Gabapentin 250 mg/5mL · Solution · Oral · Viatris Specialty LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 58151-290-35 | 5815102903558151029035 | 1 BOTTLE in 1 CARTON (58151-290-35) / 470 mL in 1 BOTTLEMarketed from Jan 14, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Neurontin
- Generic name (nonproprietary)
- gabapentin
- Active ingredients
- Gabapentin — 250 mg/5mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Viatris Specialty LLCNDC labeler code 58151
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021129
- Marketing start
- Marketing end
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 58151-290_2d43f32d-2d96-4011-84ac-507c3307dc27SPL ID 2d43f32d-2d96-4011-84ac-507c3307dc27SPL set ID 97935fd9-1d4a-43b6-a5d9-de994591187bRxCUI 105028, 105029, 105030, 261280, 261281, 283523, 310430, 310431, 310432, 310433, 310434, 351973UNII 6CW7F3G59X
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N458151029035followed by a unit qualifier and the quantityPackage 58151-0290-35. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
NEURONTIN ® is indicated for: • Management of postherpetic neuralgia in adults • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy NEURONTIN is indicated for: • Postherpetic neuralgia in adults ( 1 ) • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 58151-290
- What is NDC 58151-290?
- 58151-290 is the product NDC for Neurontin (gabapentin), Gabapentin 250 mg/5mL solution, listed with the FDA by Viatris Specialty LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Neurontin (Gabapentin).
- What is the active ingredient?
- Gabapentin.
- Who is the labeler?
- Viatris Specialty LLC, NDC labeler code 58151. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Neurontin?
- 7 other product NDCs are listed under this name. See all Neurontin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Neurontin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Neurontingabapentin | Gabapentin 300 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-282 | 58151-0282-01 |
| Neurontingabapentin | Gabapentin 400 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-283 | 58151-0283-01 |
| Neurontingabapentin | Gabapentin 600 mg/1 | Tablet, Film coatedOral | Viatris Specialty LLC | 58151-284 | 58151-0284-01 |
| Neurontingabapentin | Gabapentin 800 mg/1 | Tablet, Film coatedOral | Viatris Specialty LLC | 58151-285 | 58151-0285-01 |
| Neurontingabapentin | Gabapentin 100 mg/1 | CapsuleOral | Viatris Specialty LLC | 58151-281 | 58151-0281-01 |
| Neurontingabapentin | Gabapentin 250 mg/5mL | SolutionOral | Parke-Davis Div of Pfizer Inc | 0071-2012 | 00071-2012-47 |
| Neurontingabapentin | Gabapentin 300 mg/1 | CapsuleOral | Parke-Davis Div of Pfizer Inc | 0071-0805 | 00071-0805-24 |
Other NDCs under NDA 021129
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Gabapentin | Gabapentin 250 mg/5mL | SuspensionOral | Mylan Pharmaceuticals Inc. | 59762-5050 |
| Neurontingabapentin | Gabapentin 250 mg/5mL | SolutionOral | Parke-Davis Div of Pfizer Inc | 0071-2012 |